For over 20 years, Jason has worked closely with in-house counsel and their organizations to address a wide range of antitrust and competition law issues.
He has significant experience counseling corporate clients and ultimately litigating on their behalf to remedy the economic damages they have incurred as a result of antitrust conspiracies in markets for key inputs into their business operations. Whether the products at issue are cardboard containers or broiler chickens, Jason seeks to fully understand his client’s objective in connection with these potential affirmative recovery opportunities and then efficiently pursue that objective on their behalf while maintaining frequent communication throughout the engagement.
Jason has also represented organizations defending against class action allegations that their companies have been part of an antitrust conspiracy either to fix prices or reduce output in a variety of industries. In these engagements, Jason emphasizes the importance of quickly obtaining a fulsome understanding of the facts in order to effectively advocate for his clients. Where extensive litigation is necessary, Jason has experience with all phases of such antitrust disputes, including preparation of initial pleadings, document discovery, depositions, experts and motions for summary judgment.
Jason also has experience counseling clients on antitrust matters before state and federal regulators. For example, he recently counseled the recipient of a third-party subpoena and civil investigative demand in connection with the government’s investigation of a significant healthcare transaction.
His interest in antitrust matters dates back to his training in economics, including the study of industrial organization. Between college and law school, Jason applied that study as an economic analyst – both with the Antitrust Division of the U.S. Department of Justice and with Capitol Economics in Washington, D.C.
Jason began his law career with Jones Day in Washington, D.C., where he concentrated on antitrust counseling and litigation, including the successful defense of both a prominent price-fixing investigation and a notable merger challenge brought by an industry competitor under Section 7 of the Clayton Act.
He has also served as chairman of the Chicago Bar Association’s Antitrust Committee, as well as on the Illinois State Bar Association’s Council on Antitrust & Unfair Competition. He remains active in the national antitrust bar, and is currently serving as a vice-chair for the Healthcare & Pharmaceuticals Committee of the American Bar Association Section of Antitrust Law, where he is working on a forthcoming revision to the Committee’s Antitrust Healthcare Handbook.